Dashboard
Manage Tickers

ELDN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

eledon-pharmaceuticals-to-present-phase-2-bestow-topline-results-of-tegoprubart-in-kidney-transplant-at-asn-kidney-week-2025-on-nov-6
Eledon Pharmaceuticals To Present Phase 2 ...
10/17/2025 11:03:51

hc-wainwright--co-reiterates-buy-on-eledon-pharmaceuticals-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
09/02/2025 11:05:30

HC Wainwright & Co. analyst Yi Chen reiterates Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy and maintains $9 price ta...

eledon-pharma-q2-eps-013-beats-024-estimate
Eledon Pharma Q2 EPS $(0.13) Beats $(0.24)...
08/14/2025 20:45:02

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.24)...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/07/2025 17:09:32

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/07/2025 12:07:31

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/06/2025 21:07:28

voyager-eledon-presents-data-from-phase-1b-trial-evaluating-tegoprubart-for-prevention-of-rejection-in-kidney-transplant-patients
Voyager Eledon Presents Data From Phase 1b...
08/06/2025 20:54:31

Data from patients who remained on tegoprubart for a year showed overall mean 12-month eGFR of approximately 68 mL/min/1.73 m² ...

eledon-pharmaceutical-to-host-a-conference-call-and-webcast-on-wednesday-august-6-2025-to-discuss-updated-clinical-data-from-its-ongoing-open-label-phase-1b-study-evaluating-tegoprubart-for-the-prevention-of-rejection-in-subjects-undergoing-kidney-transplantation
Eledon Pharmaceutical To Host A Conference...
07/30/2025 20:30:50

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN) today announced...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
07/28/2025 21:05:57

craig-hallum-initiates-coverage-on-eledon-pharmaceuticals-with-buy-rating-announces-price-target-of-12
Craig-Hallum Initiates Coverage On Eledon ...
07/25/2025 17:54:47

Craig-Hallum initiates coverage on Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy rating and announces Price Target of $12.

eledon-pharma-to-present-updated-clinical-data-from-ongoing-open-label-phase-1b-study-evaluating-tegoprubart-for-prevention-of-rejection-in-subjects-undergoing-kidney-transplantation-at-wtc-2025
Eledon Pharma To Present Updated Clinical ...
07/17/2025 20:03:14

Core News & Articles
Eledon And Sernova Collaborate To Test Teg...
07/09/2025 12:36:02

Sernova Biotherapeutics ("Sernova") (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research A...

hc-wainwright--co-assumes-eledon-pharmaceuticals-at-buy-announces-price-target-of-9
HC Wainwright & Co. Assumes Eledon Pharmac...
06/18/2025 11:38:13

HC Wainwright & Co. analyst Yi Chen assumes Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy rating and announces Price T...

eledon-pharma-q1-eps-008-beats-030-estimate
Eledon Pharma Q1 EPS $(0.08) Beats $(0.30)...
05/14/2025 20:22:02

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.30)...

eledon-pharma-fy-2024-gaap-eps-075-misses-064-estimate
Eledon Pharma FY 2024 GAAP EPS $(0.75) Mis...
03/20/2025 20:11:34

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.6...

hc-wainwright--co-reiterates-buy-on-eledon-pharma-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
11/20/2024 13:17:52

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $16 price ...

eledon-pharma-q3-eps-032-misses-030-estimate
Eledon Pharma Q3 EPS $(0.32) Misses $(0.30...
11/12/2024 21:42:26

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.3...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
10/30/2024 20:31:02

eledon-pharmaceuticals-has-priced-its-underwritten-offering-of-184m-shares-at-365share-and-pre-funded-warrants-to-purchase-up-to-49m-shares-at-3649pre-funded-warrant-with-gross-proceeds-of-approximately-85m
Eledon Pharmaceuticals Has Priced Its Unde...
10/29/2024 11:59:06

eledon-pharmaceuticals-announced-data-for-the-first-three-islet-transplant-recipients-treated-with-an-immunosuppression-regimen-that-includes-tegoprubart-to-prevent-islet-transplant-rejection-in-subjects-with-type-1-diabetes
Eledon Pharmaceuticals Announced Data For ...
10/29/2024 11:47:05

First two out of three subjects treated with tegoprubart as part of immunosuppression regimen to prevent transplant rejection a...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION